11 Jun 2019

VIVA PHYSICIANS TO PARTICIPATE IN FDA HEARING ON DRUG-ELUTING AND DRUG-COATED DEVICES

On June 19-20, VIVA physicians will participate in a Food and Drug Administration Open Public Hearing to addresses the possible correlation between drug-eluting and -coated devices and late mortality at the Gaithersburg Holiday Inn Grand Ballroom in Gaithersburg, Maryland. VIVA has spearheaded a pan-industry effort to analyze patient level data

0
07 Jun 2019

SOCIAL SECURITY ERROR JEOPARDIZES MEDICARE COVERAGE FOR 250,000 SENIORS

By Susan Jaffe   At least a quarter of a million Medicare beneficiaries may receive bills for as many as five months of premiums they thought they already paid. But they shouldn’t toss the letter in the garbage. It’s not a scam or a mistake.   Because of what the

0
07 Jun 2019

A LARGE EMPLOYER ‘FRAMES’ THE ‘MEDICARE FOR ALL’ DEBATE

  By Phil Galewitz   Walk into a big-box retailer such as Walmart or Michaels and you’re likely to see MCS Industries’ picture frames, decorative mirrors or kitschy wall décor. Adjacent to a dairy farm a few miles west of downtown Easton, MCS is the nation’s largest maker of such household

0
06 Jun 2019

NAVIGATING AGING: A DOCTOR SPEAKS OUT ABOUT AGEISM IN MEDICINE

NAVIGATING AGING: A DOCTOR SPEAKS OUT ABOUT AGEISM IN MEDICINE By Judith Graham Society gives short shrift to older age. This distinct phase of life doesn’t get the same attention that’s devoted to childhood. And the special characteristics of people in their 60s, 70s, 80s and beyond are poorly under Medicine

0
05 Jun 2019

CVS still defending the Aetna merger deal 

CVS Health is making the case for its merger with Aetna to two very different audiences beginning June 3. CVS held its annual investor day and issued a long-term strategic plan to “accelerate growth” ahead of the day’s proceedings, aimed at nervous investors concerned about its recent financial performance post-merger. CVS warned that it

0
24 May 2019

USE OF BUPRENORPHINE TO TREAT OPIOID ADDICTION PROLIFERATES IN CALIFORNIA

By Harriet Blair Rowan Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible. The rate of Medi-Cal enrollees who received buprenorphine nearly quadrupled from the end of 2014 to

0
24 May 2019

ANALYSIS: A HEALTH CARE OVERHAUL COULD KILL 2 MILLION JOBS, AND THAT’S OK

By Elisabeth Rosenthal As calls for radical health reform grow louder, many on the right, in the center and in the healthcare industry are arguing that proposals like “Medicare for All” would cause economic ruin, decimating a sector that represents nearly 20% of our economy. While exploring a presidential run,

0
22 May 2019

Expiration of Temporary Medicaid Funds for Puerto Rico and USVI Would Result in Budget Shortfalls

Most of the temporary federal Medicaid funds that have supported healthcare in Puerto Rico and the U.S. Virgin Islands (USVI) in recent years and in the aftermath of the 2017 hurricanes are set to expire at the end of September, raising the prospect of steep enrollment cuts, budget shortfalls and

0
21 May 2019

HIDDEN FDA REPORTS MASKED THE SCOPE OF WIDESPREAD HARM FROM FAULTY HEART DEVICE

By Christina Jewett Faced with the possibility that a bout of abnormal heartbeats could end his life, in 2006, Dr. Marc Sicklick had a small device implanted in his chest that would shock it back into rhythm. Soon he would struggle with another life-or-death choice: whether to remove the Sprint Fidelis,

0
16 May 2019

APPLES AND ORANGES: How Obamacare, Medicare and ‘Medicare For All’ muddy the debate

By Shefali Luthra The healthcare debate has Democrats on Capitol Hill and the presidential campaign trail facing renewed pressure to make clear where they stand: Are they for “Medicare for All”? Or will they take up the push to protect the Affordable Care Act? Obamacare advocates have found a powerful

0